# Efficacy of High and Low-Dose Simvastatin on Vascular Oxidative Stress and Neurological Outcome in Patients With AIS

> **NCT03402204** · PHASE3 · COMPLETED · sponsor: **Thammasat University** · enrollment: 64 (actual)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** Simvastatin 10 mg
- **DRUG:** Simvastatin 40 mg

## Key facts

- **NCT ID:** NCT03402204
- **Lead sponsor:** Thammasat University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04-01
- **Primary completion:** 2014-10-04
- **Final completion:** 2015-12-31
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2020-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03402204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03402204, "Efficacy of High and Low-Dose Simvastatin on Vascular Oxidative Stress and Neurological Outcome in Patients With AIS". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03402204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*